Page content

Formally launched today, the €8.6m EU funded cross-border Centre for Personalised Medicine will improve clinical decision making and patient safety for dementia, diabetes, cardiovascular, acute kidney injury and emergency surgery.

Funded by the EU’s INTERREG VA Programme, managed by the Special EU Programmes Body (SEUPB), the Centre for Personalised Medicine brings together 14 academic, healthcare provider and enterprise partner organisations, working together to deliver practical solutions to clinicians to ensure that patients get the right treatment at the right time.

Personalised medicine moves away from the ‘one size, fits all’ approach, using state of the art genomics testing, technology and computing and intelligence systems to deliver a more targeted approach.

Lead investigator of the Centre, Professor Tony Bjourson, Professor of Genomics at Ulster University and Director of the Northern Ireland Centre for Stratified Medicine said:

“The Centre for Personalised Medicine will bring personalised medicine approaches to five of the most prevalent disease areas to improve the care and treatment of patients in the Northern Ireland, the border region of Ireland and Western Scotland. This collaboration extends partnership working to key clinicians in the health sector ensuring that we address real world issues across the five disease areas.”

Welcoming the project Gina McIntyre, CEO of the Special EU Programmes Body, said:

“This project reflects one of the core objectives of the INTERREG VA Programme, to improve access to healthcare services for thousands of citizens. It has great potential as it will bring together a diverse range of cross-border partners to significantly improve clinical decision-making, and personalised treatment approaches, in the fight against five of the most common diseases.”

Match-funding for this project has been provided by the Department of Business, Enterprise and Innovation in Ireland and the Department for the Economy in Northern Ireland.